Angeliq
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
50419-482 -
Package NDC
50419-482-03 -
Package NDC
50419-482-72 -
Application number
NDA021355 -
SPL ID
261d4ace-5c4e-48f6-b793-354492017e89 -
SPL set ID
761834c2-6b61-4583-84c2-f1ca4a97c4f2 -
UNII
4TI98Z838E -
UNII
N295J34A25 -
RxCUI
1483549 -
RxCUI
1483550 -
RxCUI
1483551 -
RxCUI
1483552 -
RxCUI
1483553 -
RxCUI
1483554
What the source publishes
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Active ingredients
- drospirenone and estradiol
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Angeliq",
"splId": "261d4ace-5c4e-48f6-b793-354492017e89",
"labels": [
{
"setId": "761834c2-6b61-4583-84c2-f1ca4a97c4f2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=761834c2-6b61-4583-84c2-f1ca4a97c4f2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=761834c2-6b61-4583-84c2-f1ca4a97c4f2"
}
],
"routes": [
"ORAL"
],
"labeler": "Bayer HealthCare Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "3 BLISTER PACK in 1 CARTON (50419-482-03) / 28 TABLET, FILM COATED in 1 BLISTER PACK (50419-482-01)",
"package_ndc": "50419-482-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20120229"
},
{
"sample": false,
"description": "1 BLISTER PACK in 1 CARTON (50419-482-72) / 14 TABLET, FILM COATED in 1 BLISTER PACK (50419-482-71)",
"package_ndc": "50419-482-72",
"identifierStatus": "well-formed",
"marketing_start_date": "20120229"
}
],
"productId": "50419-482_261d4ace-5c4e-48f6-b793-354492017e89",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "50419-482",
"deaSchedule": null,
"genericName": "drospirenone and estradiol",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ESTRADIOL",
"strength": ".5 mg/1"
},
{
"name": "DROSPIRENONE",
"strength": ".25 mg/1"
}
],
"applicationNumber": "NDA021355",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120229",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"M0447348",
"N0000175825",
"N0000000100",
"M0447349",
"N0000175602"
],
"unii": [
"4TI98Z838E",
"N295J34A25"
],
"rxcui": [
"1483549",
"1483550",
"1483551",
"1483552",
"1483553",
"1483554"
],
"spl_set_id": [
"761834c2-6b61-4583-84c2-f1ca4a97c4f2"
],
"pharm_class_cs": [
"Estradiol Congeners [CS]",
"Progesterone Congeners [CS]"
],
"pharm_class_epc": [
"Estrogen [EPC]",
"Progestin [EPC]"
],
"pharm_class_moa": [
"Estrogen Receptor Agonists [MoA]"
],
"manufacturer_name": [
"Bayer HealthCare Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:50419-482_261d4ace-5c4e-48f6-b793-354492017e89"